Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells
C. Rossdam, S. Brand, J. Beimdiek…·F. F. R. Buettner
The paper identifies T1LN as a glycan epitope specific to human pluripotent stem cells (hPSCs) that is rapidly downregulated during differentiation, enabling its use for immunodepletion of hPSCs from differentiated cell populations.